NNC0194-0499

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for NNC0194-0499, covering 2024-06-11 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes [Phase 1]

See pricing